Predictive Oncology Inc (NASDAQ:POAI) price on Friday, January 17, fall -9.70% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.21.
A look at the stock’s price movement, the close in the last trading session was $1.34, moving within a range at $1.19 and $1.38. The beta value (5-Year monthly) was 1.145. Turning to its 52-week performance, $3.76 and $0.55 were the 52-week high and 52-week low respectively. Overall, POAI moved 61.33% over the past month.
Predictive Oncology Inc’s market cap currently stands at around $8.06 million, with investors looking forward to this quarter’s earnings report slated for in February.
Analysts have a consensus estimate of 350k for the company’s revenue for the quarter, with a low and high estimate of 350k and 350k respectively.
Turning to the stock’s technical picture we see that short term indicators suggest on average that POAI is a 100% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend POAI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
POAI’s current price about 11.23% and 35.80% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 54.24, while 7-day volatility ratio is 13.55% and 23.80% in the 30-day chart. Further, Predictive Oncology Inc (POAI) has a beta value of 1.17, and an average true range (ATR) of 0.26.
If we refocus on Predictive Oncology Inc (NASDAQ:POAI), historical trading data shows that trading volumes averaged 6.54 over the past 10 days and 1.16 million over the past 3 months. The company’s latest data on shares outstanding shows there are 6.67 million shares.
The 2.19% of Predictive Oncology Inc’s shares are in the hands of company insiders while institutional holders own 3.03% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.15 million on 2024-10-31, giving us a short ratio of 1.26. The data shows that as of 2024-10-31 short interest in Predictive Oncology Inc (POAI) stood at 227.0 of shares outstanding, with shares short rising to 0.1 million registered in 2024-09-30. Current price change has pushed the stock 47.56% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the POAI stock continues to rise going into the next quarter.
